Breast Cancer ‘Screening Pill’ Could Be on the Horizon, Mice Study Shows

Breast Cancer ‘Screening Pill’ Could Be on the Horizon, Mice Study Shows
Researchers have developed a pill that marks tumors and lights them up when exposed to infrared light, which could potentially replace mammography in the future, a study in mice has shown. The study, “Oral Administration and Detection of a Near-Infrared Molecular Imaging Agent in an Orthotopic Mouse Model for Breast Cancer Screening,” was published in the journal Molecular Pharmaceutics. About 39 million women undergo mammograms each year in the United States. Although mammography unquestionably saves lives, increasing evidence has pointed to an overdiagnosing of breast cancer through mammography, a procedure that exposes the body to X-radiation. A recent study analyzing data in Denmark showed that about a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would not have become life-threatening. "We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from," Greg Thurber, the study’s senior author, said in a press release. In addition to the fact that mammography cannot distinguish between aggressive tumors and those that pose no mortality risk, it also has som
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.